Results 1 to 10 of about 411,751 (361)
Impact of an online lupus self-management programme in an established, population-based cohort of adults with diagnosed SLE: a mixed-methods study [PDF]
Lupus Science and MedicineObjective Strategies to Embrace Living with Lupus Fearlessly (SELF) is an online self-management education programme for people with SLE. This mixed-methods study examines SELF’s impact on patient-reported outcomes while assessing implementation outcomes
S Sam Lim +9 more
doaj +2 more sources
Living with systemic lupus erythematosus in 2020: a European patient survey
Lupus Science and Medicine, 2021 Objective The aim of this study was to analyse the 2020 burden of Systemic Lupus Erythematosus (SLE) in Europe, from the patients’ perspective.Methods In May 2020, Lupus Europe, the European umbrella patient association for SLE, designed and disseminated
Alain Cornet +3 more
doaj +1 more source
Lupus Science and Medicine, 2021 Background Use of hydroxychloroquine (HCQ) is common in patients with lupus erythematosus. Long-term use (ie, ≥5 years) and high-dose HCQ (ie, >5 mg/kg/day) are both risk factors for developing HCQ retinopathy.
Ronald F van Vollenhoven +7 more
doaj +1 more source
Membrane and Soluble CD137 in Systemic Lupus Erythematosus: Role as Biomarkers for Disease Activity
Journal of Immunology Research, 2023 Objective. The role of T cells in the pathogenesis of systemic lupus erythematosus (SLE) has recently gained attention. Costimulatory molecules are membrane proteins strictly associated with T-cell receptor (TCR), acting by activating or inhibiting T ...
Fulvia Ceccarelli +8 more
doaj +1 more source
Biomolecules, 2022 We longitudinally followed a single-center cohort of anti-phospholipid (aPL) positive healthy subjects to evaluate the evolution to systemic autoimmune diseases (sAD) and to describe clinical and serological associated features.
Fulvia Ceccarelli +10 more
doaj +1 more source
Lupus or not lupus? Neuropsychiatric symptom attribution in systemic lupus erythematosus [PDF]
Rheumatology, 2017 n ...
GOVONI, Marcello, BORTOLUZZI, Alessandra
openaire +2 more sources
Autoantibodies against complement C1q in systemic lupus erythemathosus [PDF]
, 2008 Complement and C1q, the first component of the classical pathway of activation of the complement system, are considered to be involved in the pathogenesis of systemic lupus erythematosus (SLE), a systemic autoimmune disease.
Bigler, Cornelia
core +1 more source
Efficacy and safety of rituximab in the treatment of eosinophilic granulomatosis with polyangiitis
RMD Open, 2019 Introduction Eosinophilic granulomatosis with polyangiitis (EGPA) is a subset of antineutrophil cytoplasmic antibodies (ANCA) associated vasculitis with distinct pathophysiological mechanisms, clinical features and treatment responses.
David Jayne +4 more
doaj +1 more source
Hydroxychloroquine availability during COVID-19 crisis and its effect on patient anxiety
Lupus Science and Medicine, 2021 Objective To report the results of a survey exploring the experience of patients with SLE facing hydroxychloroquine (HCQ) shortage that occurred during the early phases of the COVID-19 pandemic.Methods A survey was designed by Lupus Europe’s patient ...
Alain Cornet +3 more
doaj +1 more source